Poxel (XPAR:POXEL) Short Interest

View and export this data going back to 2015. Start your Free Trial

What is Poxel Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Poxel's Short Interest

For the Biotechnology subindustry, Poxel's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poxel's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Short Interest distribution charts can be found below:

* The bar in red indicates where Poxel's Short Interest falls into.

Poxel (XPAR:POXEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

0RA2:UK 7PO:Germany

Address

259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007

Website

https://www.poxel.com

Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines